Skip to content

General Discussion

A place to talk about whatever you want

2 Topics 5 Posts
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
  • Clarification on indication inclusion in multi-Product APS

    4
    0 Votes
    4 Posts
    80 Views
    Jennifer CarrollJ
    Hey @Supriya This appears to be a specific question about a specific piece. The piece should be submitted for assessment. The forum is for general questions. As an example, a general question here might be “Is the inclusion of an indication statement required in materials directed exclusively to healthcare professionals, where no therapeutic or pharmacologic claims are presented”. The answer to this question would be, that the indication is not required when there are no marketing benefit or therapeutic claims (see Marketing benefit claims: What are they and what level of support do they require?).
  • Welcome to your NodeBB!

    1
    0 Votes
    1 Posts
    50 Views
    No one has replied
  • Healthcare Professional Tour

    1
    0 Votes
    1 Posts
    17k Views
    No one has replied
  • Industry Tour

    1
    0 Votes
    1 Posts
    7k Views
    No one has replied
  • Patient Tour

    1
    0 Votes
    1 Posts
    2k Views
    No one has replied
  • This topic is deleted!

    1
    0 Votes
    1 Posts
    100 Views
    No one has replied